Making The Business Of Drug Adherence An Easier Pill To Swallow

Medication adherence is a big problem, and recent studies are bringing the actual costs and causes into sharper focus. At the same time, health care reforms such as electronic health records and prescriptions, as well as new incentives from the US government, have encouraged investors to tackle solutions to the problem. Questions remain about the impact of these reforms, but the companies profiled in this issue, HealthPrize Technologies, PillJogger, RxAnte and SentiCare, see an evolving climate in which their medication adherence technology solutions can turn into profitable businesses.

People don’t like to take their medicine, even when they know it’s good for them. Plenty of studies show that patients who adhere to their medication regimens enjoy better health outcomes and make less use of urgent care and inpatient hospital services, compared to patients with similar medical conditions who are not adherent. Yet shockingly low adherence rates are the norm, even for very serious diseases.

Only of late, though, have medical systems, health care providers and payors come to grips with the costs of non-adherence and begun to look for innovative ways to tackle the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America